AKANDA CORP (AKAN) Stock Price, Quote, News and Overview
NASDAQ:AKAN - Nasdaq - CA00971M4039 - Common Stock - Currency: USD
AKAN Quote, Performance and Key Statistics
AKANDA CORP
NASDAQ:AKAN (1/30/2025, 8:03:46 PM)
After market: 1.55 -0.02 (-1.27%)1.57
-0.05 (-3.09%)
The current stock price of AKAN is 1.57 USD. In the past month the price increased by 7.53%. In the past year, price decreased by -95.01%.
AKAN Latest News, Press Releases and Analysis
Top movers in Monday's after hours session
Monday's after hours session: top gainers and losers
Why Is Akanda (AKAN) Stock Up 34% Today?
Akanda stock is on the rise Friday alongside heavy pre-market trading of AKAN shares and a lack of news this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!
Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains
These 10X penny stocks may be risky but nothing ventured, nothing gained - they could rapidly rise and be 2024's best multi-bagger.
AKAN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 80.95 | 781.51B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.73 | 379.02B | ||
| JNJ | JOHNSON & JOHNSON | 15.3 | 368.05B | ||
| MRK | MERCK & CO. INC. | 16.63 | 250.31B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.7 | 220.92B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 209.42B | ||
| PFE | PFIZER INC | 10.43 | 152.50B | ||
| SNY | SANOFI-ADR | 12.99 | 135.76B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.55 | 119.95B | ||
| ZTS | ZOETIS INC | 29.98 | 77.92B | ||
| GSK | GSK PLC-SPON ADR | 8.54 | 72.14B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.83 | 43.43B |
Related stock screener links
About AKAN
Company Profile
Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The firm's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The firm also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The firm also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.
Company Info
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 107
Company Website: https://akandacorp.com/
Investor Relations: https://www.akandacorp.com/investors/
Phone: 442034889514
AKAN FAQ
What is the stock price of AKAN?
The current stock price of AKAN is 1.57 USD.
What is the symbol for AKANDA CORP stock?
The exchange symbol of AKANDA CORP is AKAN and it is listed on the Nasdaq exchange.
On which exchange is AKAN stock listed?
AKAN stock is listed on the Nasdaq exchange.
Is AKAN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AKAN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AKAN.
Does AKAN stock pay dividends?
AKAN does not pay a dividend.
When does AKAN stock report earnings?
AKAN will report earnings on 2022-12-13, before the market open.
What is the Price/Earnings (PE) ratio of AKAN?
AKAN does not have a PE ratio as the earnings reported over the last twelve months were negative (-286.63).
What is the Short Interest ratio of AKAN stock?
The outstanding short interest for AKAN is 1.05% of its float.
AKAN Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 94.91% of all stocks are doing better.
AKAN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. Both the profitability and financial health of AKAN have multiple concerns.
AKAN Financial Highlights
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -286.63. The EPS increased by -83.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -323.87% | ||
| ROE | -706.22% | ||
| Debt/Equity | 0.08 |